Compare LXRX & ELVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LXRX | ELVR |
|---|---|---|
| Founded | 1995 | 2000 |
| Country | United States | Australia |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Mining & Quarrying of Nonmetallic Minerals (No Fuels) |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 996.7M | 1.1B |
| IPO Year | 2000 | 2018 |
| Metric | LXRX | ELVR |
|---|---|---|
| Price | $2.01 | $44.64 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $4.15 | N/A |
| AVG Volume (30 Days) | ★ 2.3M | 33.9K |
| Earning Date | 05-01-2026 | 04-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 77.78 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $49,803,000.00 | N/A |
| Revenue This Year | N/A | $90.73 |
| Revenue Next Year | N/A | $42.59 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 60.24 | N/A |
| 52 Week Low | $1.10 | $21.00 |
| 52 Week High | $2.68 | $102.80 |
| Indicator | LXRX | ELVR |
|---|---|---|
| Relative Strength Index (RSI) | 36.00 | 25.65 |
| Support Level | $1.50 | $44.24 |
| Resistance Level | $2.49 | $69.04 |
| Average True Range (ATR) | 0.08 | 1.85 |
| MACD | -0.02 | -1.46 |
| Stochastic Oscillator | 27.16 | 3.21 |
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, and LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.
Elevra Lithium Ltd is a mineral exploration and development company. The principal activity of the company is lithium mining and processing at North American Lithium(NAL) and ongoing identification, evaluation and development of its world-wide portfolio of mineral exploration assets, predominantly focusing on lithium. Its segments are North American Lithium, and All other operations. Majority of revenue comes from North American Lithium. It has presence in China, and USA. Majority of revenue comes from China.